Colleen Moretti

January 28, 2023

The treatment previously demonstrated significantly improved overall survival for patients with recurrent glioblastoma in a phase 1 study.

January 27, 2023

The Food and Drug Administration approved Orserdu for patients with ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer.

January 21, 2023

The multicenter study is evaluating the safety and efficacy of nanrilkefusp alfa combined with Erbitux.

January 19, 2023

The trial is evaluating the safety and efficacy of AVB-001 patients with relapsed refractory ovarian cancer.

January 17, 2023

Compared with CT based radiotherapy, MRI-guided treatment resulted in fewer side effects for patients with prostate cancer.

January 16, 2023

Patients with blood cancer may develop serious infections after transplants, but a T-cell therapy may improve symptoms and side effects.

January 11, 2023

Treatment for breast cancer, such a chemotherapy, may cause a decline in working memory, processing speed, attention and more for patients.

January 06, 2023

Investigators have administered Keytruda and ONC-392 the first patients with platinum resistant ovarian cancer.

January 05, 2023

A phase 2 trial evaluating EVX-01 plus Keytruda (pembrolizumab) in patients with metastatic melanoma may continue, the FDA said.

January 03, 2023

AAV2-hAQP1 was safe and effective in treating patients with dry mouth symptoms, which is often a result of some cancer treatments like radiation, according to phase 1 study results.

January 02, 2023

The targeted therapy appeared to be safe and effective in treating patients with KRAS G12C mutated pancreatic cancer, according to results from a recent study.

January 02, 2023

Patients with non-muscle invasive bladder cancer who currently smoke or previously smoked should consider quitting to possibly improve health outcomes in survivorship, according to an expert.

January 02, 2023

The combination met its main goal of progression-free survival and secondary goal of overall survival.

December 27, 2022

As a part of its “Speaking Out” video series, CURE® spoke with Meryl Uranga, on behalf of KidneyCAN, about the importance of working as a team with their clinicians and getting educated before making decisions.

December 25, 2022

Although triplet therapy may be effective and tolerable for patients with BRAF-mutant melanoma, each patient’s case should be considered before deciding if it is the right course of treatment, according to an expert.

December 23, 2022

Some patients are at higher risk of infection, so it’s critical that they keep their care team up to date on any symptoms.

December 22, 2022

The past 20 years have brought great advances to advocacy groups, helping to improve patients’ quality of life. But more work is needed to raise awareness in underserved groups.

December 22, 2022

It is important that caregivers take care of not only the patient, but also themselves, as the diagnosis may affect their mental health.

December 22, 2022

If approved by the FDA, zanidatamab could be the first HER-2 targeted therapy for patients with biliary tract cancers.

December 17, 2022

This is the only first-line trial to show benefit with immuno-oncology plus chemotherapy in patients with advanced or recurrent endometrial cancer.

December 15, 2022

Patients with non-muscle invasive bladder cancer who smoke should consider quitting to possibly improve health outcomes in survivorship, according to an expert.

December 14, 2022

Watch Dr. John Mascarenhas, from the Icahn School of Medicine at Mount Sinai, discuss future treatments for polycythemia vera, during the CURE Educated Patient MPN Summit.

December 13, 2022

Improvements may not be seen right away, but patients with non-metastatic breast cancer should stay compliant to practicing yoga to possibly improve quality of life, according to an expert.

December 08, 2022

Robert Atteberry never gave up, even after three cancer diagnoses, and has found a motivation and passion for competing in triathlons during survivorship.

December 07, 2022

It is important for survivors to maintain healthy oral hygiene because they face increased risk of dental problems.

December 06, 2022

Children with acute lymphoblastic leukemia had a 2.4-fold greater risk of relapse if they were considered extremely obese while undergoing maintenance therapy.

December 06, 2022

The internet is flooded with information for cancer survivors, and it is vital they recognize the reliable sources from those that are not.

December 05, 2022

A kidney cancer diagnosis may negatively affect a patient’s mental health; however, exercise may help put them at ease.

December 05, 2022

Testicular cancer survivors should talk with their care team if they are experiencing symptoms of anxiety, depression or sexual dysfunction.

December 04, 2022

Watch Dr. Benjamin T. Diamond, from Sylvester Comprehensive Cancer Center at the University of Miami, discuss the role of sustained MRD negativity during the CURE® Educated Patient® Multiple Myeloma Summit.